Comparative genomics allowed the identification of drug targets against human fungal pathogens.

dc.contributorANA KARINA R. ABADIO, UNB
dc.contributorERIKA S. KIOSHIMA, UNB
dc.contributorMARCUS M. TEIXEIRA, UNB
dc.contributorNATALIA FLORENCIO MARTINS, CENARGEN
dc.contributorBERNARD MAIGRET, UNIVERSITY HENRI POINCARÉ-NANCY I
dc.contributorMARIA SUELI S. FELIPE, UNB.
dc.creatorABADIO, A. K. R.
dc.creatorKIOSHIMA, E. S.
dc.creatorTEIXEIRA, M. M.
dc.creatorMARTINS, N. F.
dc.creatorMAIGRET, B.
dc.creatorFELIPE, M. S. S.
dc.date2023-02-23T17:57:37Z
dc.date2023-02-23T17:57:37Z
dc.date2012-01-06
dc.date2011
dc.date.accessioned2026-07-07T11:54:20Z
dc.identifierBMC Genomics, 12:75, 2011. (Open access)
dc.identifierhttp://www.alice.cnptia.embrapa.br/alice/handle/doc/911938
dc.identifier.urihttp://hdl.handle.net/123456789/517015
dc.languageeng
dc.rightsopenAccess
dc.subjectFungal infections
dc.subjecthuman diseases
dc.titleComparative genomics allowed the identification of drug targets against human fungal pathogens.
dc.typeArtigo de periódico

Archivos